Global gynecology drugs market is anticipated to grow with an impressive CAGR in the forecast years, 2022-2026, on the account of rapidly increasing instances of gynecology cancer, and other gynecology disorders. These diseases have increased the fatality rate of the women population in the last five years. Thus, the government is now working on creating awareness and alerting the women population towards keeping check of their personal wellbeing and gynae health issues. These inferences are anticipated to substantiate the growth of the market in the forecast years. Moreover, lifestyle changes among women are also expected to drive the market growth. With increasing number of working women and their employment into various industries, the chances of infection and diseases due to prolonged exposure to harmful chemicals and toxins would influence the growth of the global gynecology drugs market.

Gynecology drugs are therapeutics and biologics that are administered for the treatment of gynecology disorders, and ailments to the women patient. Gynecology disorders affects the reproductive system of the females and causes infection, or functional failure in the reproductive organs like uterus, urinary bladder, urethra, ovaries, appendages, etc. Recent developments in the gynecology therapeutics and technologically advanced devices for the early diagnosis of the gynecology disorders is driving the growth of the market in the future five years.

The global gynecology drugs market is segmented by therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on therapeutics, the market is further bifurcated between hormonal therapy and non-hormonal therapy. Non-hormonal therapy is anticipated to hold the largest share of the market due to the advantages of the non-hormonal therapy on the efficient treatments. Moreover, rapid advancements in new products and the development advances are supporting the growth of the market segment in the next five years. Hormonal therapy is also expected to hold the significant share of the market owing to the rising demand of new technologically advanced medicine, although the therapy has certain side effects such as the risk of breast cancer.

Major companies in the market are Eli Lilly and Company Ltd., Pfizer Inc., Merck & Co., Inc., Amgen Inc., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Allergan Plc., Bayer AG, Abbott Laboratories Ltd., AbbVie Inc., GlaxoSmithKline Plc, Novartis Ltd., Lupin Pharmaceuticals, Inc., Johnson and Johnson Inc., Sanofi SA, among others. The market players are actively involved in the technological advancements of the therapeutics as well as research and development of the medical devices involved with the administrations of the gynecology drugs. Other strategies include partnerships among the market players.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of global gynecology drugs market from 2016 to 2020.
  • To estimate and forecast the market size of global gynecology drugs market from 2021 to 2026 and growth rate until 2026. 
  • To classify and forecast global gynecology drugs market based on therapeutics, indication, distribution channel, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global gynecology drugs market.
  • To identify drivers and challenges for global gynecology drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global gynecology drugs market.
  • To identify and analyze the profile of leading players operating in global gynecology drugs market.
  • To identify key sustainable strategies adopted by market players in global gynecology drugs market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global gynecology drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributers and suppliers of products and other stakeholders
  • Organizations, forums, and alliances related to gynecology drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global gynecology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Gynecology Drugs Market, By Therapeutics:
    • Hormonal Therapy
    • Non-Hormonal Therapy
  • Global Gynecology Drugs Market, By Indication:
    • Gynecology Cancers
    • Endometriosis
    • Female Infertility
    • Menopausal Disorder
    • Gynecology Infections
    • Polycystic Ovary Syndrome
    • Contraception
  • Global Gynecology Drugs Market, By Distribution Channel:
    • Hospitals & Clinics
    • Diagnostic Centers
    • Ambulatory Care Centers
    • Others
  • Global Gynecology Drugs Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global gynecology drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Gynecology Drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

1.     Product Overview

2.     Research Methodology

3.     Impact of COVID-19 on Global Gynecology Drugs Market

4.     Executive Summary

5.     Voice of Customer

6.     Global Gynecology Drugs Market Outlook

6.1.   Market Size & Forecast

6.1.1.      By Value

6.2.   Market Share & Forecast

6.2.1.      By Therapeutics (Hormonal Therapy vs. Non-Hormonal Therapy)

6.2.2.      By Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome and Contraception)

6.2.3.      By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

6.2.4.      By Company (2020)

6.2.5.      By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

6.3.   Product Market Map

7.     North America Gynecology Drugs Market Outlook

7.1.   Market Size & Forecast          

7.1.1.      By Value

7.2.   Market Share & Forecast

7.2.1.      By Therapeutics

7.2.2.      By Indication

7.2.3.      By Distribution Channel

7.2.4.      By Country (United States; Canada; Mexico)

7.3.   North America: Country Analysis

7.3.1.      United States Gynecology Drugs Market Outlook

7.3.1.1.           Market Size & Forecast

7.3.1.1.1.                By Value

7.3.1.2.           Market Share & Forecast

7.3.1.2.1.                By Therapeutics

7.3.1.2.2.                By Indication

7.3.1.2.3.                By Distribution Channel

7.3.2.      Canada Gynecology Drugs Market Outlook

7.3.2.1.           Market Size & Forecast

7.3.2.1.1.                By Value

7.3.2.2.           Market Share & Forecast

7.3.2.2.1.                By Therapeutics

7.3.2.2.2.                By Indication

7.3.2.2.3.                By Distribution Channel

7.3.3.      Mexico Gynecology Drugs Market Outlook

7.3.3.1.           Market Size & Forecast

7.3.3.1.1.                By Value

7.3.3.2.           Market Share & Forecast

7.3.3.2.1.                By Therapeutics

7.3.3.2.2.                By Indication

7.3.3.2.3.                By Distribution Channel

8.     Europe Gynecology Drugs Market Outlook

8.1.   Market Size & Forecast          

8.1.1.      By Value

8.2.   Market Share & Forecast

8.2.1.      By Therapeutics

8.2.2.      By Indication

8.2.3.      By Distribution Channel

8.2.4.      By Country (France; Germany; UK; Italy; Spain)

8.3.   Europe: Country Analysis

8.3.1.      France Gynecology Drugs Market Outlook

8.3.1.1.           Market Size & Forecast

8.3.1.1.1.                By Value

8.3.1.2.           Market Share & Forecast

8.3.1.2.1.                By Therapeutics

8.3.1.2.2.                By Indication

8.3.1.2.3.                By Distribution Channel

8.3.2.      Germany Gynecology Drugs Market Outlook

8.3.2.1.           Market Size & Forecast

8.3.2.1.1.                By Value

8.3.2.2.           Market Share & Forecast

8.3.2.2.1.                By Therapeutics

8.3.2.2.2.                By Indication

8.3.2.2.3.                By Distribution Channel

8.3.3.      United Kingdom Gynecology Drugs Market Outlook

8.3.3.1.           Market Size & Forecast

8.3.3.1.1.                By Value

8.3.3.2.           Market Share & Forecast

8.3.3.2.1.                By Therapeutics

8.3.3.2.2.                By Indication

8.3.3.2.3.                By Distribution Channel

8.3.4.      Italy Gynecology Drugs Market Outlook

8.3.4.1.           Market Size & Forecast

8.3.4.1.1.                By Value

8.3.4.2.           Market Share & Forecast

8.3.4.2.1.                By Therapeutics

8.3.4.2.2.                By Indication

8.3.4.2.3.                By Distribution Channel

8.3.5.      Spain Gynecology Drugs Market Outlook

8.3.5.1.           Market Size & Forecast

8.3.5.1.1.                By Value

8.3.5.2.           Market Share & Forecast

8.3.5.2.1.                By Therapeutics

8.3.5.2.2.                By Indication

8.3.5.2.3.                By Distribution Channel

9.     Asia-Pacific Gynecology Drugs Market Outlook

9.1.   Market Size & Forecast          

9.1.1.      By Value

9.2.   Market Share & Forecast

9.2.1.      By Therapeutics

9.2.2.      By Indication

9.2.3.      By Distribution Channel

9.2.4.      By Country (China; India; Japan; South Korea; Australia)

9.3.   Asia Pacific: Country Analysis

9.3.1.      India Gynecology Drugs Market Outlook

9.3.1.1.           Market Size & Forecast

9.3.1.1.1.                By Value

9.3.1.2.           Market Share & Forecast

9.3.1.2.1.                By Therapeutics

9.3.1.2.2.                By Indication

9.3.1.2.3.                By Distribution Channel

9.3.2.      China Gynecology Drugs Market Outlook

9.3.2.1.           Market Size & Forecast

9.3.2.1.1.                By Value

9.3.2.2.           Market Share & Forecast

9.3.2.2.1.                By Therapeutics

9.3.2.2.2.                By Indication

9.3.2.2.3.                By Distribution Channel

9.3.3.      Japan Gynecology Drugs Market Outlook

9.3.3.1.           Market Size & Forecast

9.3.3.1.1.                By Value

9.3.3.2.           Market Share & Forecast

9.3.3.2.1.                By Therapeutics

9.3.3.2.2.                By Indication

9.3.3.2.3.                By Distribution Channel

9.3.4.      South Korea Gynecology Drugs Market Outlook

9.3.4.1.           Market Size & Forecast

9.3.4.1.1.                By Value

9.3.4.2.           Market Share & Forecast

9.3.4.2.1.                By Therapeutics

9.3.4.2.2.                By Indication

9.3.4.2.3.                By Distribution Channel

9.3.5.      Australia Gynecology Drugs Market Outlook

9.3.5.1.           Market Size & Forecast

9.3.5.1.1.                By Value

9.3.5.2.           Market Share & Forecast

9.3.5.2.1.                By Therapeutics

9.3.5.2.2.                By Indication

9.3.5.2.3.                By Distribution Channel

10.  Middle East and Africa Gynecology Drugs Market Outlook

10.1.                 Market Size & Forecast

10.1.1.   By Value

10.2.                 Market Share & Forecast

10.2.1.   By Therapeutics

10.2.2.   By Indication

10.2.3.   By Distribution Channel

10.2.4.   By Country (UAE; Saudi Arabia; South Africa)

10.3.                 MEA: Country Analysis

10.3.1.   South Africa Gynecology Drugs Market Outlook

10.3.1.1.        Market Size & Forecast

10.3.1.1.1.             By Value

10.3.1.2.        Market Share & Forecast

10.3.1.2.1.             By Therapeutics

10.3.1.2.2.             By Indication

10.3.1.2.3.             By Distribution Channel

10.3.2.   Saudi Arabia Gynecology Drugs Market Outlook

10.3.2.1.        Market Size & Forecast

10.3.2.1.1.             By Value

10.3.2.2.        Market Share & Forecast

10.3.2.2.1.             By Therapeutics

10.3.2.2.2.             By Indication

10.3.2.2.3.             By Distribution Channel

10.3.3.   UAE Gynecology Drugs Market Outlook

10.3.3.1.        Market Size & Forecast

10.3.3.1.1.             By Value

10.3.3.2.        Market Share & Forecast

10.3.3.2.1.             By Therapeutics

10.3.3.2.2.             By Indication

10.3.3.2.3.             By Distribution Channel

11.  South America Gynecology Drugs Market Outlook

11.1.                 Market Size & Forecast

11.1.1.   By Value

11.2.                 Market Share & Forecast

11.2.1.   By Therapeutics

11.2.2.   By Indication

11.2.3.   By Distribution Channel

11.2.4.   By Country (Brazil; Argentina; Colombia)

11.3.                 South America: Country Analysis

11.3.1.   Brazil Gynecology Drugs Market Outlook

11.3.1.1.        Market Size & Forecast

11.3.1.1.1.             By Value

11.3.1.2.        Market Share & Forecast

11.3.1.2.1.             By Therapeutics

11.3.1.2.2.             By Indication

11.3.1.2.3.             By Distribution Channel

11.3.2.   Argentina Gynecology Drugs Market Outlook

11.3.2.1.        Market Size & Forecast

11.3.2.1.1.             By Value

11.3.2.2.        Market Share & Forecast

11.3.2.2.1.             By Therapeutics

11.3.2.2.2.             By Indication

11.3.2.2.3.             By Distribution Channel

11.3.3.   Colombia Gynecology Drugs Market Outlook

11.3.3.1.        Market Size & Forecast

11.3.3.1.1.             By Value

11.3.3.2.        Market Share & Forecast

11.3.3.2.1.             By Therapeutics

11.3.3.2.2.             By Indication

11.3.3.2.3.             By Distribution Channel

12.  Market Dynamics

12.1.                 Drivers

12.2.                 Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.                 Competition Outlook

14.2.                 Global Players Profiled (Leading Companies)

14.2.1.   Eli Lilly and Company Ltd.

14.2.2.   Pfizer Inc.

14.2.3.   Merck & Co., Inc.

14.2.4.   Amgen Inc.

14.2.5.   AstraZeneca Plc

14.2.6.   F. Hoffmann-La Roche Ltd.

14.2.7.   Allergan Plc.

14.2.8.   Bayer AG

14.2.9.   Abbott Laboratories Ltd.

14.2.10.                   AbbVie Inc.

14.2.11.                   GlaxoSmithKline Plc

14.2.12.                   Novartis Ltd.

14.2.13.                   Lupin Pharmaceuticals, Inc.

14.2.14.                   Johnson and Johnson Inc.

14.2.15.                   Sanofi SA

15.  Strategic Recommendations

16.  About Us & Disclaimer

  • Figure 1: Global Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 2: Global Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 3: Global Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 4: Global Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F  

    Figure 5: Global Gynecology Drugs Market Share, By Company, By Value, 2020

    Figure 6: Global Gynecology Drugs Market Share, By Region, By Value, 2016-2026F

    Figure 7: Global Gynecology Drugs Product Market Map, By Value, 2016-2026F

    Figure 8: North America Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 9: North America Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 10: North America Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 11: North America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 12: North America Gynecology Drugs Market Share, By Country, By Value, 2016-2026F

    Figure 13: United States Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 14: United States Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 15: United States Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 16: United States Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 17: Canada Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 18: Canada Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 19: Canada Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 20: Canada Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 21: Mexico Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 22: Mexico Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 23: Mexico Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 24: Mexico Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 25: Europe Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 26: Europe Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 27: Europe Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 28: Europe Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 29: Europe Gynecology Drugs Market Share, By Country, By Value, 2016-2026F

    Figure 30: Germany Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 31: Germany Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 32: Germany Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 33: Germany Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 34: France Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 35: France Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 36: France Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 37: France Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 38: United Kingdom Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 39: United Kingdom Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 40: United Kingdom Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 41: United Kingdom Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 42: Italy Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 43: Italy Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 44: Italy Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 45: Italy Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 46: Spain Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 47: Spain Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 48: Spain Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 49: Spain Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 50: APAC Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 51: APAC Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 52: APAC Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 53: APAC Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 54: APAC Gynecology Drugs Market Share, By Country, By Value, 2016-2026F

    Figure 55: China Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 56: China Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 57: China Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 58: China Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 59: Japan Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 60: Japan Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 61: Japan Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 62: Japan Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 63: India Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 64: India Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 65: India Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 66: India Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 67: Australia Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 68: Australia Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 69: Australia Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 70: Australia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 71: South Korea Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 72: South Korea Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 73: South Korea Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 74: South Korea Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 75: South America Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 76: South America Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 77: South America Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 78: South America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 79: South America Gynecology Drugs Market Share, By Country, By Value, 2016-2026F

    Figure 80: Brazil Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 81: Brazil Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 82: Brazil Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 83: Brazil Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 84: Argentina Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 85: Argentina Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 86: Argentina Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 87: Argentina Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F  

    Figure 88: Colombia Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 89: Colombia Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 90: Colombia Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 91: Colombia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 92: MEA Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 93: MEA Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 94: MEA Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 95: MEA Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 96: MEA Gynecology Drugs Market Share, By Country, By Value, 2016-2026F

    Figure 97: South Africa Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 98: South Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F  

    Figure 99: South Africa Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 100: South Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 101: Saudi Arabia Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 102: Saudi Arabia Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 103: Saudi Arabia Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 104: Saudi Arabia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 105: UAE Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F

    Figure 106: UAE Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F

    Figure 107: UAE Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F

    Figure 108: UAE Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F